Investors
As of 30 November 2001, the Cognis Group has been owned by a consortium of private equity funds advised by Permira, Goldman Sachs and SV Life Sciences.
| Pioneers in Investment Banking |
 |
GS Capital Partners is the private equity arm of Goldman Sachs, one of the world’s oldest investment banking and security firms. Since ist inception in 1986, the group has invested approximately US$ 11 billion in approximately 500 companies and currently compromises a team of over 100 private equity professionals – 32 of them in Europe. In July 2000, the latest global fund amounting to US$5.25 billion was raised. GS Capital Partners today has a highly diversified global portfolio. Notable investments include Wincor Nixdorf, Polo Ralph Lauren, Onion Power and Kookmin Bank. One of the latest projects has been the joint acquisition – together with Allianz Capital Partners – of Messer Griesheim from Aventis, which closed in April 2001.
The Fund invests primarily in service industry businesses. The Fund also will consider private companies, new companies that have or are developing relationships with established businesses, companies that were formerly units of larger corporations and new franchises with a proven track record.
http://www.goldmansachs.com/ |
|
| About Permira |
 |
|
Permira is a European private equity firm with an international reach. Our funds, raised from pension funds and other institutions, make long-term investments in companies with the ambition of transforming their performance and driving sustainable growth.
The firm's teams are based in Frankfurt, Guernsey, Hong Kong, London, Luxembourg, Madrid, Milan, New York, Paris, Menlo Park, Stockholm and Tokyo, advising funds with a total committed capital of approximately EUR20 billion (US$28 billion). Since 1985, the Permira Funds have completed over 190 private equity transactions.
For more information visit: www.permira.com |
|
| Investing in Life Sciences |
 |
|
SV Life Sciences ('SVLS'), is a life sciences focused venture capital adviser and manager. SVLS advised or managed funds from corporate and private investors make selected investments in entrepreneurs and management teams operating businesses at all stages of development requiring funding within the human life sciences sector including biotechnology and pharmaceuticals, medical devices and instruments, healthcare IT and services. SVLS currently advises or manages five funds with capital commitments of approximately $1.6bn which primarily invest in North America and Europe, but will consider innovative investments in other regions. Our team of 28 professionals has a diverse, complimentary set of skills and experience that allow us to tailor a team to work with almost any life sciences business.
SVLS was established in 1993, and operated as Schroder Ventures Life Sciences until our name was changed on 1 January 2005, and currently has offices in Boston, London and San Francisco.
http://www.svlsa.com/ |